U.S. markets close in 1 minute

Astellas Pharma Inc. (ALPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
15.70+0.10 (+0.67%)
As of 9:30AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

Currency in JPY. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
3/31/2020
3/31/2019
3/31/2018
Total Revenue
1,253,215,000
1,300,843,000
1,306,348,000
1,300,316,000
Cost of Revenue
242,833,000
276,739,000
292,050,000
294,250,000
Gross Profit
1,010,382,000
1,024,104,000
1,014,299,000
1,006,066,000
Operating Expense
844,833,000
778,452,000
768,760,000
790,388,000
Operating Income
165,549,000
245,652,000
245,539,000
215,678,000
Net Non Operating Interest Income Expense
4,590,000
1,359,000
5,056,000
4,855,000
Pretax Income
170,392,000
245,350,000
248,967,000
218,113,000
Tax Provision
32,085,000
49,939,000
26,702,000
53,434,000
Net Income Common Stockholders
138,307,000
195,411,000
222,265,000
164,679,000
Diluted NI Available to Com Stockholders
138,307,000
195,411,000
222,265,000
164,679,000
Basic EPS
-
104.15
115.05
81.11
Diluted EPS
-
104.08
114.94
81.02
Basic Average Shares
-
1,876,193
1,931,882
2,030,203
Diluted Average Shares
-
1,877,548
1,933,748
2,032,472
Total Operating Income as Reported
165,803,000
243,991,000
243,912,000
213,258,000
Total Expenses
1,087,666,000
1,055,191,000
1,060,810,000
1,084,638,000
Net Income from Continuing & Discontinued Operation
138,307,000
195,411,000
222,265,000
164,679,000
Normalized Income
138,307,000
195,411,000
222,265,000
164,679,000
Interest Income
7,036,000
4,363,000
6,358,000
6,637,000
Interest Expense
2,446,000
3,004,000
1,302,000
1,782,000
Net Interest Income
4,590,000
1,359,000
5,056,000
4,855,000
EBIT
172,838,000
248,354,000
250,269,000
219,895,000
EBITDA
245,029,000
-
-
-
Reconciled Cost of Revenue
242,833,000
276,739,000
292,050,000
294,250,000
Reconciled Depreciation
72,191,000
66,396,000
63,458,000
64,863,000
Net Income from Continuing Operation Net Minority Interest
138,307,000
195,411,000
222,265,000
164,679,000
Normalized EBITDA
245,029,000
314,750,000
313,727,000
284,758,000
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0